Harpoon Therapeutics, Inc. announced that Julie Eastland has been named President, effective November 8, 2021. Ms. Eastland will succeed Jerry McMahon, Ph.D., who has resigned from his position as President and as a member of the company?s Board of Directors. Dr. McMahon has entered into a retirement and transition agreement with Harpoon and will serve as an advisor. Ms. Eastland currently serves on the Harpoon Board and will continue in that role. In addition, Scott Myers, also a Board member, has been named Chair of the Harpoon Board. Julie Eastland joined the Harpoon Board in 2018 and her career spans more than 20 years of executive leadership in the biotechnology industry. Most recently she served as Chief Operating Officer and Chief Financial Officer of ReCode Therapeutics.